![Benefici dei Nuovi farmaci Anticoagulanti Orali (NAO): facili da assumere, efficaci, meno pericolosi! – Cardiologo Dr. Cosmo Godino Benefici dei Nuovi farmaci Anticoagulanti Orali (NAO): facili da assumere, efficaci, meno pericolosi! – Cardiologo Dr. Cosmo Godino](http://www.cardiologo-cosmogodino.it/wp-content/uploads/2020/04/benefici-495x400.jpg)
Benefici dei Nuovi farmaci Anticoagulanti Orali (NAO): facili da assumere, efficaci, meno pericolosi! – Cardiologo Dr. Cosmo Godino
![Farmaci per la trombosi venosa profonda - Disturbi dell'apparato cardiovascolare - Manuali MSD Edizione Professionisti Farmaci per la trombosi venosa profonda - Disturbi dell'apparato cardiovascolare - Manuali MSD Edizione Professionisti](https://www.msdmanuals.com/-/media/manual/professional/images/h/e/m/hem_pathways_coagulation_drugs_it.gif?thn=0&sc_lang=it)
Farmaci per la trombosi venosa profonda - Disturbi dell'apparato cardiovascolare - Manuali MSD Edizione Professionisti
![PDF) Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery PDF) Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery](https://i1.rgstatic.net/publication/356676411_Comparative_Risk_of_Bleeding_of_Anticoagulant_Therapy_with_Vitamin_K_Antagonists_VKAs_and_with_Non-Vitamin_K_Antagonists_in_Patients_Undergoing_Dental_Surgery/links/61a79215aade5b1bf5f88643/largepreview.png)
PDF) Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery
![Growing evidence for the effectiveness of FXa inhibition Professor Cedric HERMANS MD, MRCP(UK), PhD Division of Haematology Cliniques universitaires Saint-Luc. - ppt download Growing evidence for the effectiveness of FXa inhibition Professor Cedric HERMANS MD, MRCP(UK), PhD Division of Haematology Cliniques universitaires Saint-Luc. - ppt download](https://images.slideplayer.com/20/5935122/slides/slide_13.jpg)
Growing evidence for the effectiveness of FXa inhibition Professor Cedric HERMANS MD, MRCP(UK), PhD Division of Haematology Cliniques universitaires Saint-Luc. - ppt download
![Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1885585720302723:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1NG5aYZW0B0aV0Fg3mbGNokhKK6/UKttlLci9JQWxsX0DjO4SxdsT+MV4HIjS9oXinQl9SvKCXNUvEOUdsFpvaKJoLbHW5fXsdOazCVwHGNiOnBYuHKF0qIWe+ci2m6e9i581cwbqVIO56yNwo1BngGzrRTYGVMT23rl9cNc9Y/GeByKoK2sgTTC4qch7RBMaGVuU2AfKZctfv7+FQs5coA4uda16aMDjYOlhke6oplpQ=)
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
![Nuovi anticoagulanti orali: considerazioni di farmacologia clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca Nuovi anticoagulanti orali: considerazioni di farmacologia clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca](https://www.giornaledicardiologia.it/allegati/02076_2015_11/images/imgs_02.jpg)
Nuovi anticoagulanti orali: considerazioni di farmacologia clinica | Giornale Italiano di Cardiologia - Organo ufficiale di Italian Federation of Cardiology e Società Italiana di Chirurgia Cardiaca
![PDF) [Morbidity and mortality in patients treated with oral anticoagulants] | Jordi Gol-Freixa and Jordi Fontcuberta - Academia.edu PDF) [Morbidity and mortality in patients treated with oral anticoagulants] | Jordi Gol-Freixa and Jordi Fontcuberta - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50832789/mini_magick20190127-11614-1j1u47p.png?1548608235)
PDF) [Morbidity and mortality in patients treated with oral anticoagulants] | Jordi Gol-Freixa and Jordi Fontcuberta - Academia.edu
![2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal of the American 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal of the American](https://www.jacc.org/cms/asset/fd115859-312f-48f4-8ab4-a8012aff6982/gr2.jpg)